当前位置：
X-MOL 学术
›
Eur. J. Nucl. Med. Mol. Imaging
›
论文详情
Our official English website, www.x-mol.net, welcomes your
feedback! (Note: you will need to create a separate account there.)
Editorial Commentary: Should “heterogeneous response” be considered as new category for assessing treatment response in patients with breast cancer?
European Journal of Nuclear Medicine and Molecular Imaging ( IF 8.6 ) Pub Date : 2024-12-21 , DOI: 10.1007/s00259-024-07042-9 Sofia C. Vaz, David Groheux, Thiemo van Nijnatten, Lidija Antunovic, Fatima Cardoso, Felix Mottaghy, Maria Joao Cardoso, Christopher Riedl, Lioe-Fee de Geus-Oei, Gary A. Ulaner
中文翻译：
编者评论：“异质性反应”是否应被视为评估乳腺癌患者治疗反应的新类别？
更新日期：2024-12-21
European Journal of Nuclear Medicine and Molecular Imaging ( IF 8.6 ) Pub Date : 2024-12-21 , DOI: 10.1007/s00259-024-07042-9 Sofia C. Vaz, David Groheux, Thiemo van Nijnatten, Lidija Antunovic, Fatima Cardoso, Felix Mottaghy, Maria Joao Cardoso, Christopher Riedl, Lioe-Fee de Geus-Oei, Gary A. Ulaner
中文翻译：
编者评论：“异质性反应”是否应被视为评估乳腺癌患者治疗反应的新类别？
京公网安备 11010802027423号